methamphetamine has been researched along with carbamates in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Barnett, A; Peschil, E | 1 |
Gösswald, R; Wirth, W | 1 |
Chavant, F; Duranti, A; Francheteau, M; Gennequin, B; Maccarrone, M; Makriyannis, A; Nader, J; Rapino, C; Solinas, M; Thiriet, N | 1 |
Fukumori, R; Nawata, Y; Yamaguchi, T; Yamamoto, T | 1 |
Ebrahimi-Ghiri, M; Khakpai, F; Zarrindast, MR | 1 |
5 other study(ies) available for methamphetamine and carbamates
Article | Year |
---|---|
Potentiation of methamphetamine aggregate toxicity in mice by diethyldithiocarbomate.
Topics: Animals; Carbamates; Drug Synergism; Methamphetamine; Mice | 1968 |
[Pharmacological research in the diphenylcarbamic acid thio ester series. II].
Topics: Abnormalities, Drug-Induced; Analgesics; Animals; Antidotes; Atropine; Behavior, Animal; Carbamates; Cats; Central Nervous System; Cricetinae; Dogs; Electroencephalography; Female; Fetus; Insecticides; Methamphetamine; Mice; Nicotine; Parasympatholytics; Pregnancy; Rabbits; Rats; Reflex | 1965 |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors.
Topics: Animals; Arachidonic Acids; Benzamides; Benzodioxoles; Cannabinoid Receptor Modulators; Carbamates; Central Nervous System Stimulants; Dronabinol; Endocannabinoids; Enzyme Inhibitors; Glycerides; Male; Methamphetamine; Mice, Inbred C57BL; Neostriatum; Neurotoxicity Syndromes; Piperidines; Polyunsaturated Alkamides; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2014 |
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.
Topics: Amidohydrolases; Amphetamine-Related Disorders; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Addictive; Behavior, Animal; Benzamides; Benzodioxoles; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Male; Maze Learning; Methamphetamine; Monoacylglycerol Lipases; Piperidines; Rats; Rats, Wistar | 2019 |
URB597 abrogates anxiogenic and depressive behaviors in the methamphetamine-withdrawal mice: Role of the cannabinoid receptor type 1, cannabinoid receptor type 2, and transient receptor potential vanilloid 1 channels.
Topics: Amidohydrolases; Animals; Anxiety; Behavior, Animal; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Central Nervous System Stimulants; Depression; Disease Models, Animal; Endocannabinoids; Male; Methamphetamine; Mice; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substance Withdrawal Syndrome; TRPV Cation Channels | 2021 |